FDA UDI In Commercial Distribution 🇺🇸 United States

Dermagraft

DI: 00618474000015 · Model: 1 · ORGANOGENESIS INC.
Product Codes
1
GMDN Terms
1
Identifiers
1
Pkg Device Count
1

Basic Information

Brand Name
Dermagraft
Primary DI
00618474000015
Version / Model
1
Company Name
ORGANOGENESIS INC.
Labeler DUNS
152165817
Distribution Status
In Commercial Distribution
Device Count in Pkg
1
Record Status
Published
Publish Date
2014-09-24
Public Version
3
Public Version Date
2018-07-06
Public Version Status
Update
Public Device Record Key
17ff0e99-7199-44d1-b844-9bde6d4ca4e7

Device Description

Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers greater than six weeks duration, which extend through the dermis, but without tendon, muscle, joint capsule, or bone exposure. Dermagraft should be used in conjunction with standard wound care regimens and in patients that have adequate blood supply to the involved foot.

Device Characteristics

Single Use
Yes
Prescription Use (Rx)
Yes
Over the Counter (OTC)
No
Kit
No
Combination Product
No
HCT/P
Yes
Contains NRL
No
Not Made with NRL
No
MRI Safety
Labeling does not contain MRI Safety Information
Direct Marking Exempt
No
PM Exempt
No
Has Serial Number
No
Has Lot/Batch Number
Yes
Has Manufacturing Date
No
Has Expiration Date
Yes
Has Donation ID
No

Sterilization

Is Sterile
No
Sterilization Prior Use
No

Product Codes

Code Name
PFC Cultured Human Cell Skin Dressing

GMDN Terms

Code Name
46170 Skin regeneration template, human-/animal-derived

Identifiers

Type ID
Primary 00618474000015

Customer Contacts

Premarket Submissions

Submission Number Supplement Number
BP003600 00

Storage Conditions

Type
Storage Environment Temperature
Temperature Range
-85 – -65 Degrees Celsius